8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                 ---------------



                                    FORM 8-K

                                CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


Date of report (date of earliest event reported)     June 24, 2002
                                                --------------------------------



                         Retractable Technologies, Inc.
- --------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)



         Texas                    000-30885              75-2599762
- --------------------------------------------------------------------------------
(State or Other Jurisdiction      (Commission            (IRS Employer
      of Incorporation)           File Number)           Identification No.)



511 Lobo Lane, Little Elm, Texas                               75068-0009
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices)                       (Zip Code)



Registrant's telephone number, including area code   (972) 294-1010
                                                  ------------------------------


                                      None
- --------------------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)



ITEM 5.           OTHER EVENTS

     On June 24, 2002, the Registrant issued a press release, a copy of which is
attached to this Form 8-K as exhibit 99.

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

c.      Exhibits

99.     Press Release of Retractable Technologies, Inc. issued June 24, 2002.


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

DATE: June 24, 2002                      RETRACTABLE TECHNOLOGIES, INC.
                                         (Registrant)

                                         BY: /s/ THOMAS J. SHAW
                                                --------------------------------
                                                 THOMAS J. SHAW
                                                 CHAIRMAN, PRESIDENT, AND
                                                 CHIEF EXECUTIVE OFFICER




                                INDEX TO EXHIBITS

EXHIBIT NO.   DESCRIPTION
- -----------   -----------

99            Press Release of Retractable Technologies, Inc. issued
              June 24, 2002

EX-99

                                                                      EXHIBIT 99

RETRACTABLE TECHNOLOGIES SIGNS AGREEMENT TO PRODUCE VANISHPOINT SAFETY SYRINGES
IN CHINA FOR GLOBAL MARKET

LITTLE ELM, Texas, June 24, 2002 -- Retractable Technologies, Inc. (AMEX:RVP), a
leading maker of safety needle devices, announced today that it has signed a
long-term agreement with Double Dove Co., Ltd., the largest syringe maker in the
People's Republic of China, to produce its line of VanishPoint(R) safety
syringes for worldwide distribution.

The deal vastly improves Retractable's economies of scale without requiring any
capital investment by the company. Under this arrangement, Double Dove will
supply syringes to Retractable at an average unit cost of 8.5 cents, fully
packaged, sterilized and ready for use by healthcare workers. This low cost for
finished goods will allow Retractable to market its products at prices
comparable to those of conventional, non-safety syringes, thereby enabling
healthcare facilities in countries from Armenia to Zimbabwe to afford syringes
that prevent not only accidental needlesticks but also needle reuse, which is a
major cause of the spread of AIDS and hepatitis C in the Third World. The
agreement also calls for Double Dove to manufacture safety syringes exclusively
for Retractable.

Double Dove is expected to begin shipping VanishPoint(R) devices to Retractable
customers in about three months from its PuDong facility near Shanghai, where
approximately 100,000 square feet will be dedicated to VanishPoint(R)
production. The company, which currently produces more than one billion units of
its own syringes each year, mainly for the Chinese market, will also assist
Retractable in marketing the VanishPoint(R) line in China. Retractable will
continue to manufacture its needle devices for the U. S. market at its
headquarters facility in Little Elm.

Thomas J. Shaw, Retractable's president and CEO, said: "Our deal with Double
Dove, one of the largest and most respected companies in China, is the first of
its kind in the needle safety industry in that we achieve high volume production
economies from the very start. If you combine this new international competitive
edge with the fact that our products are already recognized as the safest and
best overall, we become a serious contender for the world market of
approximately 30 billion units annually." He added: "This is a giant step in our
effort to protect healthcare workers in lesser developed countries from
potentially deadly accidental needlestick injuries."

After a thorough study of all safety needle products available worldwide, Double
Dove initiated the deal with Retractable through its U. S. subsidiary, Double
Dove USA. Li Xianyu, president of Double Dove, said, "This is a very important
milestone for us. Without a doubt, the Retractable Technologies design and
engineering is superior to all others that we have examined. We are gratified in
knowing that due to our capabilities, these products will now be available to
prevent accidental needlestick injuries throughout the world, including lesser
developed countries."

Retractable Technologies, Inc. manufactures and markets VanishPoint(R) automated
retraction safety syringes and blood collection devices, which virtually
eliminate healthcare worker exposure to accidental needlestick injuries. These
revolutionary devices use a patented friction ring mechanism that causes the
contaminated needle to retract automatically from the patient into the barrel of
the device.

Forward-looking statements in this press release are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995 and
reflect the company's current views with respect to future events. The company
believes that the expectations reflected in such forward-looking statements are
accurate. However, the company cannot assure you that such expectations will
occur. The company's actual future performance could differ materially from such
statements. Factors that could cause or contribute to such differences include,
but are not limited to: the impact of dramatic increases in demand; the
company's ability to quickly increase its production capacity in the event of a
dramatic increase in demand; the company's ability to access the market; the
company's ability to continue to finance research and development as well as
operations and expansion of production through equity and debt financing, as
well


as sales; the increased interest of larger market players in
providing safety needle devices and other risks and uncertainties that are
detailed from time to time in the company's periodic reports filed with the
Securities and Exchange Commission.

For more information on Retractable, visit our Web site at www.vanishpoint.com.

Contact:

Retractable Technologies, Inc., Little Elm
Investor Contact:
Douglas W. Cowan, 888/806-2626 or 972/294-1010
rtifinancial@vanishpoint.com
   or
Media Contact:
Phillip L. Zweig, 508/627-9717
214/912-7415 (cell)
plzweig@aol.com
   or
Double Dove USA
Ramzi Abulhaj, 305/620-4007
ramzia@vitalcare.com